---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-22-000015"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2022-03-21T23:59:59+00:00"
generated_at: "2026-06-26T21:31:14.798017+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Haemonetics appoints James D'Arecca as CFO effective April 11, 2022; Burke to retire

## Summary
- James D'Arecca appointed CFO effective April 11, 2022; William Burke steps down as CFO on that date.
- D'Arecca previously CFO at TherapeuticsMD; prior roles at Allergan, Bausch & Lomb, Merck, PwC.
- Compensation: $525k base salary, 75% target bonus, $1.1M LTI target, $400k sign-on bonus.
- Initial equity grant valued at $600k: 50% RSUs, 50% options, vesting 25% annually over 4 years.

## SEC filing metadata
- accession: 0000313143-22-000015
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2022-03-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314322000015/0000313143-22-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314322000015/hae-20220321.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-22-000015
- JSON: https://secwatch.observer/filing/0000313143-22-000015.json
- Plain text: https://secwatch.observer/filing/0000313143-22-000015.txt

## Key facts
- Executive change
  James C. D'Arecca was appointed as Chief Financial Officer at HAEMONETICS CORP.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On March 21, 2022, the Company announced the appointment of James C. D’Arecca as its Chief Financial Officer, effective April 11, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/313143/000031314322000015/0000313143-22-000015-index.htm
- Executive change
  William P. Burke retired as Chief Financial Officer at HAEMONETICS CORP.
  - Action: retired
  - Role: Chief Financial Officer
  source text: Mr. Burke will step down as Chief Financial Officer and principal financial officer of the Company on April 11, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/313143/000031314322000015/0000313143-22-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.